Mine Güllüoğlu

Mine Güllüoğlu

Auto-generated profile, based on publicly available information

Mine Güllüoğlu

Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in International Surgery
Verified
Journal Article
Open access
TBTurker Bulut
Turker Bulut
ECEmel Canbay
Emel Canbay
SYSumer Yamaner
Sumer Yamaner
MGMine Gulluoglu
Mine Gulluoglu
DBDursun Bugra
Dursun Bugra
Solitary rectal ulcer syndrome (SRUS) is a rare condition with various causes that results in ischemic injury. The aim of this study was to assess the clinical findings, diagnosis, and outcomes of treatment in patients with SRUS. Between 1992 and 2006, a retrospective review was undertaken for all patients diagnosed with SRUS. Fifty-eight patients were diagnosed with SRUS. Among patients with paradoxic rectal spasm (PRS), lesions disappeared in 1 of 3 given applied biofeedback treatment, and in 2 of 4 injected with Botulinum toxin (BotoxTM). Twenty-three patients underwent appropriate surgical treatment. Overall, postoperative improvement was seen in 18 patients (78.2%). In conclusion, every patient with SRUS must be assessed for causative disease. Treatment should include conservative approaches such as Botox injection; in patients with pelvic floor disorders, surgical treatment should be considered.

15 March 2023 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
EÖErsan Özaslan
Ersan Özaslan
FGFulya Günşar
Fulya Günşar
AÖAslı Çiftçibaşı Örmeci
Aslı Çiftçibaşı Örmeci
IHİbRahim Hatemi
İbRahim Hatemi
CECumali Efe
Cumali Efe
RIRamazan İdIlman
Ramazan İdIlman
Autoimmune hepatitis (AIH) is a rare, immune-mediated liver disease. It has a heterogeneous nature with varied clinical presentations. The management of patients with AIH is challenging in many ways. The main difficulties are inexperience due to the rarity of the disease, diagnostic confusion in controversial areas such as variant/overlap cases, acute presentations, the presence of non-alcoholic fatty liver disease or drug-induced liver injury features, and the long and complex course of treatment. Here, we provide a clear, concise, and visualized review regarding the diagnosis and treatment of AIH, including illustrative cases.

1 August 2005 in Annals of Diagnostic Pathology
Verified
Journal Article
Closed access
DYDilek Yilmazbayhan
Dilek Yilmazbayhan
LALora Esberk Ates
Lora Esberk Ates
ŞDŞükrü Dilege
Şükrü Dilege
MGMıne Gulluoglu
Mıne Gulluoglu
STSerhan Tanju
Serhan Tanju
GKGoksel Kalayci
Goksel Kalayci

27 March 2024 in Hepatology International
Verified
Journal Article
Open access
PDF file
MBMelek Büyük
Melek Büyük
NBNeslihan Berker
Neslihan Berker
DBDoğu Vurallı Bakkaloğlu
Doğu Vurallı Bakkaloğlu
IŞİbrahim Volkan Şenkal
İbrahim Volkan Şenkal
ZOZerrin Onal
Zerrin Onal
MGMine Güllüoğlu
Mine Güllüoğlu
Aim: Idiopathic non-cirrhotic portal hypertension (INCPH) is a vascular disorder of uncertain origin. Diagnosis can be challenging on liver biopsy. Despite diverse histomorphologic findings documented in literature, studies on the frequency of these findings are lacking. This study aims to assess both the histomorphologic features and the immunoexpression patterns of CD34 and glutamine synthetase (GS) in liver biopsies and searched for their contribution to the pathologic diagnosis of INCPH. Materials and methods: Hematoxylin–eosin, CD34, and GS-stained liver needle biopsy sections of 16 patients clinically diagnosed with INCPH were retrospectively analyzed. Histologic findings such as portal vein narrowing, obliteration, or loss were grouped as major findings, while portal vein herniation, hypervascularized portal tracts, and periportal abnormal vessels were grouped as minor findings, and their frequency were evaluated. Periportal endothelial CD34 stained areas were measured via ocular micrometer. The distribution of GS immunoexpression was evaluated. Eighteen healthy liver donor biopsies were evaluated as controls. Results: In INCPH cases, 58% of portal tracts showed major findings, compared to 15% in the control group (p < 0.001). Minor findings were observed in 16% of INCPH cases and 7% of controls (p = 0.014). The number of portal tracts with histologic findings is significantly higher in INCPH than in control liver biopsies. Abnormal portal tract distribution, like being close to each other, was seen in 75% of INCPH cases but not in controls (p < 0.001). Nodular regenerative hyperplasia (NRH) was present in 31% of cases. Periportal CD34 expression was higher in INCPH, and affected areas were larger than in controls (p < 0.001). Irregular GS staining, i.e. GS staining with patchy distribution in zone 3, and/or periportal and zone 2 hepatocytes, was found in 62% of INCPH cases, while controls showed the usual pattern (p < 0.001). Conclusion: In the biopsy diagnosis of INCPH, in addition to the presence of major histologic findings and the amount of portal tracts displaying these features, the expression of endothelial CD34 in periportal areas, and irregular hepatocellular GS expression can also be considered as supporting feature.

1 January 2021 in Hepatology Forum
Verified
Journal Article
Open access
PDF file
HTHandan Yarkan Tugsal
Handan Yarkan Tugsal
SYSelcen Yüksel
Selcen Yüksel
GKGökhan Kabacam
Gökhan Kabacam
SESami Evirgen
Sami Evirgen
KAKubra Akan
Kubra Akan
HBHakan Bozkaya
Hakan Bozkaya
Background and Aim: This study was designed to predict the fibrosis stage with a clinical scoring system that may reduce the need for liver biopsy. Materials and Methods: The study cohort included the treatment of 430 chronic hepatitis B (CHB) and 170 chronic hepatitis C (CHC) of naive patients. The patients were divided into two groups as mild to moderate and severe fibrosis. After an index obtained in the study cohort, the index was tested in a validation cohort and compared with the FIB-4 Index. Results: The AUC of CHC index was found of 0.89 the sensitivity of 0.91 the specificity of 0.74, the positive predictive value (PPV) of 0.54 and the negative predictive value (NPV) of 0.96. The FIB-4 Index was applied to the CHC study cohort and the ATA Index Hepatitis C was found to be superior in terms of AUC (0.89–0.82), sensitivity (0.91–0.76) and NPV (0.96–0.86). The AUC of CHB Index was determined of 0.92, the sensitivity of 0.90, the specificity of 0.84, the PPV of 0.53 and the NPV of 0.98. Compared to the FIB-4 Index in CHB study cohort, the ATA Index Hepatitis B was predominant in terms of AUC (0.92–0.88), sensitivity (0.90–0.75), NPV (0.98–0.94) and PPV (0.53–0.49). Conclusion: ATA Indexes can predict the non-existence of severe fibrosis with an accuracy similar to FIB-4 Index and may reduce the need for liver biopsy.

1 July 2025 in Rheumatology International
Verified
Journal Article
Open access
PDF file
MBMurat Bektaş
Murat Bektaş
BÇBilger Çavuş
Bilger Çavuş
BABesim Fazıl Ağargün
Besim Fazıl Ağargün
IŞİbRahim Volkan Şenkal
İbRahim Volkan Şenkal
NKNevzat Koca
Nevzat Koca
AGAhmet Gül
Ahmet Gül
To evaluate the utility of elasticity imaging techniques, such as transient elastography (FibroScan), in assessing the liver and transplanted kidney in patients with AA amyloidosis (AA-A). This study was conducted in patients with AA-A, while patients with immunoglobulin light chain amyloidosis (AL-A), Familial Mediterranean Fever (FMF) without amyloidosis, and healthy controls (HC) were included as comparison groups for liver stiffness (LS) measurements. Additionally, kidney stiffness (KS) was measured in renal transplant recipients (RTRs) with transplants due to AA-A or other causes of chronic renal failure. LS evaluations were performed in 65 patients with AA-A, 14 with AL-A, 20 with FMF, and 27 with HC. LS (kPa) was significantly higher [median (IQR)] in patients with AA-A [6.4 (5.4)] and AL-A [9.8 (11)] compared to HC [4.7 (1.7)] (p < 0.001). However, the difference between AL-A and AA-A was not statistically significant. LS values were comparable in FMF-AA patients with [6.8 (6.6)] and without [5.7 (3.6)] liver involvement, and FMF patients without amyloidosis [7.15 (4.6)]. The median KS values were comparable in 19 AA-A and 16 disease controls. However, KS values were significantly higher in patients with recurrent amyloidosis in the transplanted kidney [29.3 (18.9)] compared to those without recurrence [10.9 (7.7)] (p = 0.003). In our study, increased liver stiffness measurements were observed in patients with AA-A, AL-A, and FMF compared to HC. Transient elastography using FibroScan appears to be a promising non-invasive tool for assessing liver involvement in AA-A and may aid in detecting recurrence of amyloidosis in transplanted kidneys. Further studies are needed to validate the utility of FibroScan in evaluating the involvement of the liver and kidneys in patients with AA-A.